290 related articles for article (PubMed ID: 36275707)
1. GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells
Thapaliya M; Amponnawarat A; Tesmer JJG; Ali H
Front Immunol; 2022; 13():1032497. PubMed ID: 36275707
[TBL] [Abstract][Full Text] [Related]
2. GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells.
Thapaliya M; Ali H
Front Immunol; 2023; 14():1155777. PubMed ID: 37063868
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.
Bawazir M; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
Front Immunol; 2022; 13():1033794. PubMed ID: 36275683
[TBL] [Abstract][Full Text] [Related]
4. Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells
Amponnawarat A; Chompunud Na Ayudhya C; Ali H
Front Immunol; 2021; 12():689410. PubMed ID: 34248979
[No Abstract] [Full Text] [Related]
5. MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants.
Chompunud Na Ayudhya C; Amponnawarat A; Roy S; Oskeritzian CA; Ali H
Cells; 2021 Jan; 10(1):. PubMed ID: 33467419
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Orai Channel Function Regulates Mas-Related G Protein-Coupled Receptor-Mediated Responses in Mast Cells.
Chaki S; Alkanfari I; Roy S; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
Front Immunol; 2021; 12():803335. PubMed ID: 35126366
[TBL] [Abstract][Full Text] [Related]
7. DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis.
Kunimura K; Akiyoshi S; Uruno T; Matsubara K; Sakata D; Morino K; Hirotani K; Fukui Y
J Allergy Clin Immunol; 2023 Jun; 151(6):1585-1594.e9. PubMed ID: 36804596
[TBL] [Abstract][Full Text] [Related]
8. Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation.
Adhikari N; Shim WS
Arch Pharm Res; 2022 Sep; 45(9):644-657. PubMed ID: 36183260
[TBL] [Abstract][Full Text] [Related]
9. Small-Molecule Host-Defense Peptide Mimetic Antibacterial and Antifungal Agents Activate Human and Mouse Mast Cells via Mas-Related GPCRs.
Alkanfari I; Freeman KB; Roy S; Jahan T; Scott RW; Ali H
Cells; 2019 Apr; 8(4):. PubMed ID: 30987258
[TBL] [Abstract][Full Text] [Related]
10. Lactic acid suppresses MRGPRX2 mediated mast cell responses.
Syed M; Kammala AK; Callahan B; Oskeritzian CA; Subramanian H
Cell Immunol; 2021 Oct; 368():104422. PubMed ID: 34399172
[TBL] [Abstract][Full Text] [Related]
11. SG-SP1 Suppresses Mast Cell-Mediated Allergic Inflammation via Inhibition of FcεRI Signaling.
Kim MJ; Je IG; Song J; Fei X; Lee S; Yang H; Kang W; Jang YH; Seo SY; Kim SH
Front Immunol; 2020; 11():50. PubMed ID: 32063904
[No Abstract] [Full Text] [Related]
12. New insight into prurigo nodularis: Proadrenomedullin N-terminal 20 peptide mediates mouse mast cell activation via Mrgprb2.
Shao Y; Xiao Z; Jin Y; Zhu Y; Shen Y; Jin T; Tang H; Wang D
Skin Res Technol; 2024 Feb; 30(2):e13588. PubMed ID: 38284237
[TBL] [Abstract][Full Text] [Related]
13. Recent Knowledge and Insights on the Mechanisms of Immediate Hypersensitivity and Anaphylaxis: IgE/FcεRI- and Non-IgE/FcεRI-Dependent Anaphylaxis.
Ebo DG; Beyens M; Heremans K; van der Poorten MM; Van Gasse AL; Mertens C; Houdt MV; Sabato V; Elst J
Curr Pharm Des; 2023; 29(3):178-184. PubMed ID: 36284380
[TBL] [Abstract][Full Text] [Related]
14. MRGPRX2 is essential for sinomenine hydrochloride induced anaphylactoid reactions.
Liu R; Che D; Zhao T; Pundir P; Cao J; Lv Y; Wang J; Ma P; Fu J; Wang N; Wang X; Zhang T; Dong X; He L
Biochem Pharmacol; 2017 Dec; 146():214-223. PubMed ID: 28987593
[TBL] [Abstract][Full Text] [Related]
15. Thimerosal induces skin pseudo-allergic reaction via Mas-related G-protein coupled receptor B2.
Peng B; Che D; Hao Y; Zheng Y; Liu R; Qian Y; Cao J; Wang J; Zhang Y; He L; Geng S
J Dermatol Sci; 2019 Sep; 95(3):99-106. PubMed ID: 31558225
[TBL] [Abstract][Full Text] [Related]
16. Gold induces a pseudo-allergic reaction via MRGPRX2 both in vitro and in vivo.
Zeng Y; Wang J; Zhang Y; Ge S; Wu Y; Fan T; Wang N
Cell Immunol; 2019 Jul; 341():103923. PubMed ID: 31076078
[TBL] [Abstract][Full Text] [Related]
17. Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent.
Liu R; Hu S; Zhang Y; Che D; Cao J; Wang J; Zhao T; Jia Q; Wang N; Zhang T
Int Immunopharmacol; 2019 May; 70():417-427. PubMed ID: 30856392
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory function of Shikonin on MRGPRX2-mediated pseudo-allergic reactions induced by the secretagogue.
Wang J; Zhang Y; Li C; Ding Y; Hu S; An H
Phytomedicine; 2020 Mar; 68():153149. PubMed ID: 32032836
[TBL] [Abstract][Full Text] [Related]
19. Isosalvianolic acid C-induced pseudo-allergic reactions via the mast cell specific receptor MRGPRX2.
Lin Y; Wang J; Hou Y; Fu J; Wei D; Jia Q; Lv Y; Wang C; Han S; He L
Int Immunopharmacol; 2019 Jun; 71():22-31. PubMed ID: 30875538
[TBL] [Abstract][Full Text] [Related]
20. MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms and distinguishing MRGPRX2- and IgE/FcεRI-mediated events.
Baldo BA
Br J Clin Pharmacol; 2023 Nov; 89(11):3232-3246. PubMed ID: 37430437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
